Get in touch
Please contact us to discuss how working with Myriad Associates can maximise and secure R&D funding opportunities for your business.
Horizon 2020 has nearly €80 billion of grant funding available over 7 years (2014 to 2020). The goal is to ensure Europe produces world-class science, removes barriers to innovation, and makes it easier for the public and private sectors to work together in delivering innovation.
Horizon 2020 is the biggest ever EU research and innovation programme. The goal is to ensure Europe produces world-class science, removes barriers to innovation, and makes it easier for the public and private sectors to work together in delivering innovation.
Horizon 2020 has nearly €80 billion of funding available over 7 years (2014 to 2020). Funding opportunities are set out in two-year work programmes that cover the large majority of support available. Most projects require you to be part of a consortium, usually made up of at least 3 organisations from different countries.
The funding rates depend on the type of project:
The work you are doing should be truly innovative. In addition, many Horizon 2020 main scheme calls require a consortium of at least 3 partners from three different EU Member States, with involvement from a mix of academics and scientists, research organisations, SMEs, and industry partners.
If your project goes beyond incremental change and is truly groundbreaking, the Horizon 2020 main scheme may be the right funding opportunity for you. Your project will need to improve the overall scientific output of Europe and speed up results through internationalisation, collaboration, and creating long-term benefits.
The Horizon 2020 work programme for 2016-17 supports a range of initiatives that cover nearly 600 topics. You may be able to get Horizon 2020 funding for projects which:
It takes over 400 hours of work to prepare a Horizon 2020 main scheme application.
You will need the right combination of people to cover the proposal’s key aspects: the technology, market knowledge, commercialisation plan, and financial details. If your call requires a consortium, it should be a blend of academics and scientists, SMEs, universities, research organisations, and industry partners.
There are both single-stage and two-stage evaluations. The type of evaluation you will have depends on the call for proposals.
In a single-stage evaluation, if your proposal is eligible and in scope, each evaluator scores the proposal according to three main criteria (‘excellence’, ‘impact’, and ‘quality and efficiency of the implementation’, with each marked out of 5. If your call has an innovation action, the ‘impact’ criterion is usually weighted 1.5 times more.
The proposal then goes to a consensus group, to find agreement on the comments and scores, and then to a panel review. The proposal receives a ranking, and those projects above a certain threshold are chosen to be funded.
The two-stage process is similar to the single-stage evaluation, except that you submit a short proposal which evaluators mark only on the ‘excellence’ and ‘impact’ criteria. If your proposal is above a certain threshold (usually 8 out of 10), you proceed to stage two.
In stage 2, you submit the full proposal, which is evaluated according to the single-stage evaluation process.
The overall success rate was 14% from the first 100 calls for Horizon 2020 proposals, which closed by 1 December 2014.
An effective Horizon 2020 main scheme application successfully describes the commercial, technological, and financial benefits of the project in a precise and compelling manner. Horizon 2020 grants are often awarded to projects considered too risky for private sector investment.
Proposed R&D projects and costs must also be realistic, with a clear commercial opportunity, and aim to create new markets or exploit significant growth.
It is crucial to keep the European point of view in mind and ensure that you highlight that your project:
A Horizon 2020 main scheme application is examined by at least three independent experts in the area of innovation identified in the application. In many cases, the application is examined by five or more experts.
For Horizon 2020 main scheme proposals, the grant body aims to provide a decision within 5 months of the submission deadline.
For the Horizon 2020 main scheme, funding is based on the reimbursement of costs, although a certain amount is granted at the beginning of the project.
There are three main payment types for the funding of Horizon 2020 projects:
Myriad Associates have an enviable track record with R&D grant applications. Using our grant application services can give you a significant competitive advantage over other grant applicants.
We assess your chances of success
We write your grant application
We prepare your financial plan
We submit your grant application
We help you comply with the conditions of your grant
We take care of your application from start to finish
Project Assessment – Our specialist consultants discuss all the relevant technical, commercial and financial details of your R&D project with you and assess your chances of success.
Workshop Session – We will take you through a workshop session so that we fully understand your project in terms of the technical problems and solution, commercial opportunities, market dynamics, project team and financial projections.
Grant Writing – We research, prepare, and write an award-winning R&D grant application for your review and approval.
Submission and Feedback – We complete the online registration process and submit the web-based grant application on your behalf. Grant assessors provide feedback on both successful and unsuccessful grant applications, and we review this feedback with you to give you on-going advice and guidance.
Compliance and Monitoring – When your grant application is approved, we help you comply with all requests from the grant body’s monitoring officers.
You can download our information sheet on Horizon 2020 Main Scheme grants.
This R&D tax credits calculator estimates the amount of corporation tax savings you may be entitled to by making a claim for R&D tax relief.